Diffuse lamellar keratitis after corneal crosslinking in a patient with post-laser in situ keratomileusis corneal ectasia.

Détails

ID Serval
serval:BIB_19A12EC55A1D
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Diffuse lamellar keratitis after corneal crosslinking in a patient with post-laser in situ keratomileusis corneal ectasia.
Périodique
Journal of cataract and refractive surgery
Auteur⸱e⸱s
Kymionis G.D., Bouzoukis D.I., Diakonis V.F., Portaliou D.M., Pallikaris A.I., Yoo S.H.
ISSN
0886-3350 (Print)
ISSN-L
0886-3350
Statut éditorial
Publié
Date de publication
12/2007
Peer-reviewed
Oui
Volume
33
Numéro
12
Pages
2135-2137
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Publication Status: ppublish
Résumé
A 27-year-old man presented with corneal ectasia in his left eye 4 years after myopic laser in situ keratomileusis (LASIK) and was treated with riboflavin-ultraviolet-A (crosslinking). During the first post-treatment days, diffuse lamellar keratitis (DLK) (stage III) developed. The microbiology culture was negative. After intensive treatment with topical corticosteroids, the DLK resolved during the following 2 weeks. Crosslinking for post-LASIK corneal ectasia may induce DLK. Early diagnosis and appropriate treatment with intensive topical corticosteroids is essential to successfully manage this post-crosslinking complication.
Mots-clé
Adult, Collagen/metabolism, Corneal Diseases/drug therapy, Corneal Diseases/etiology, Corneal Diseases/metabolism, Dexamethasone/therapeutic use, Dilatation, Pathologic/drug therapy, Dilatation, Pathologic/etiology, Dilatation, Pathologic/metabolism, Glucocorticoids/therapeutic use, Humans, Keratitis/drug therapy, Keratitis/etiology, Keratomileusis, Laser In Situ/adverse effects, Male, Myopia/surgery, Photosensitizing Agents/adverse effects, Riboflavin/adverse effects, Ultraviolet Rays
Pubmed
Web of science
Création de la notice
02/10/2019 9:57
Dernière modification de la notice
06/10/2019 6:26
Données d'usage